This UK report aims to raise awareness of an often overlooked population, to promote greater understanding of support needs and recommend approaches that offer better, high quality care. 16 pages. Last reviewed March 2019.

This billingual article describes the findings of a cross-sectional, self-administered survey of Canadian family physicians and other health professionals investigating perceived barriers and enablers of advance care planning (ACP) in the primary care setting. 9 pages. Last reviewed March 2019.

This study underscores the need to consider gender identify and sexual orientation at end-of-life. In particular, recognition of intersectionality and social locations is crucial to facilitating positive aging experiences and end-of-life care. 10 pages. Last reviewed March 2019.

This publication summarizes the literature on the evidence of using endocannabinoid system medications and their ability to modulate neuroinflammation and oxidative stress in Alzheimer’s Disease. 15 pages. Last reviewed March 2019.

The authors described the findings of a cross-sectional study which provided empirical evidence that prolonged use of inhaled or ingested street cannabis in patients with MS is associated with poorer performance on cognitive domains commonly affected in this population. 8 pages. Last reviewed March 2019.

This publication describes the findings of a review of medical marijuana (1948-2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy and movement disorders. 8 pages. Last reviewed March 2019.

This article reviews the findings of a randomized, double-blind, placebo-controlled study that sought evidence for the efficacy of low-dose TCH in reducing neuropsychiatric symptoms of dementia.  9 pages. Last reviewed March 2019.

The authors attempted to present concise date on cannabis pharmacology related to THC and CBD including methods of administration and dosing recommendations.  9 pages. Last reviewed March 2019.

The authors sought to review the benefits and adverse events of cannabinoids through a review of twenty-eight databases from inception to April 2015. 18 pages. Last reviewed March 2019.

This report aimed to provide comprehensive review of the then current evidence regarding the health effects of using cannabis and cannabis-derived products.  468 pages. Last reviewed March 2019.

Pages